Glioblastoma survival in the United States before and during the temozolomide era
By D. Johnson, B. O’Neill. Journal of Neuro-Oncology, 2012
710 citations recorded by the source corpus.
Subfields: Genetics, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/e1e400bf554114e3ab3ccc7f4d6c7adca0b172fc
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Genetics
In Pulmonary and Respiratory Medicine
In Radiology, Nuclear Medicine and Imaging
Citations in the corpus
- m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells (2017, background): “Even with the combined surgical resection, radiation therapy, and chemotherapy, median survival of patients is less than 15 months after diagnosis (Stupp et al., 2009; Johnson and O'Neill, 2012).”
- Aquaporin water channels in the nervous system (2013, neutral): “Even with extensive surgical debulking, radiotherapy and chemotherapy, the median survival time for individuals with glioblastoma is less than 1 year from diagnosis 123 .”
- Glioblastoma: Overview of Disease and Treatment (2016, methodology): “An analysis by Johnson and O’Neill (2012) demonstrated a statistically significant improvement in OS since the onset of aggressive multimodality treatment.”